{"title":"Effects of Multiple Intravenous Doses of Perioperative Vitamin C on Pain Management Following Total Hip Arthroplasty.","authors":"Guangtao Han, Yuna Ye, Pengde Kang","doi":"10.2147/DDDT.S506262","DOIUrl":null,"url":null,"abstract":"<p><strong>Purpose: </strong>Although the benefits of numerous intravenous vitamin C doses during the perioperative phase on postoperative pain following total hip arthroplasty for whether patients could have pain relief for a longer period of time have not yet been tested, a single dose of vitamin C can assist control pain after the procedure on the first post-operative day.</p><p><strong>Methods: </strong>One hundred patients undergoing total hip arthroplasty (THA) at our institution were enrolled in this prospective, double-blind, placebo-controlled, randomized experiment. These patients were randomized to either the control group or the vitamin C group. While the control group received an equivalent daily dose of a placebo, the vitamin C group received an intravenous injection of 3g of vitamin C every day during the perioperative period. Ten milliliters of morphine were injected subcutaneously as a rescue analgesic for patients who complained of discomfort following surgery. The amount of morphine used for rescue analgesia and the levels of inflammatory markers were the main outcomes that we evaluated. Additionally, we evaluated postoperative pain and hip joint recovery using the Visual Analog Scale (VAS) as secondary outcomes.</p><p><strong>Results: </strong>In the vitamin C group, the subcutaneous morphine injection dosage was considerably lower (0-24h 6.1mg ± 2.7mg vs 4.0mg ± 2.9mg, p = 0.000, total use 8.3mg ± 3.1mg vs 6.6mg ± 3.9mg, p = 0.018). During the perioperative term, the vitamin C group experienced better hip motion and lower VAS pain levels at rest and during exercise.</p>","PeriodicalId":11290,"journal":{"name":"Drug Design, Development and Therapy","volume":"19 ","pages":"2667-2675"},"PeriodicalIF":4.7000,"publicationDate":"2025-04-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11995280/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Drug Design, Development and Therapy","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.2147/DDDT.S506262","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/1 0:00:00","PubModel":"eCollection","JCR":"Q1","JCRName":"CHEMISTRY, MEDICINAL","Score":null,"Total":0}
引用次数: 0
Abstract
Purpose: Although the benefits of numerous intravenous vitamin C doses during the perioperative phase on postoperative pain following total hip arthroplasty for whether patients could have pain relief for a longer period of time have not yet been tested, a single dose of vitamin C can assist control pain after the procedure on the first post-operative day.
Methods: One hundred patients undergoing total hip arthroplasty (THA) at our institution were enrolled in this prospective, double-blind, placebo-controlled, randomized experiment. These patients were randomized to either the control group or the vitamin C group. While the control group received an equivalent daily dose of a placebo, the vitamin C group received an intravenous injection of 3g of vitamin C every day during the perioperative period. Ten milliliters of morphine were injected subcutaneously as a rescue analgesic for patients who complained of discomfort following surgery. The amount of morphine used for rescue analgesia and the levels of inflammatory markers were the main outcomes that we evaluated. Additionally, we evaluated postoperative pain and hip joint recovery using the Visual Analog Scale (VAS) as secondary outcomes.
Results: In the vitamin C group, the subcutaneous morphine injection dosage was considerably lower (0-24h 6.1mg ± 2.7mg vs 4.0mg ± 2.9mg, p = 0.000, total use 8.3mg ± 3.1mg vs 6.6mg ± 3.9mg, p = 0.018). During the perioperative term, the vitamin C group experienced better hip motion and lower VAS pain levels at rest and during exercise.
目的:尽管围手术期多次静脉注射维生素C对全髋关节置换术后疼痛的益处是否能在较长时间内缓解疼痛尚未得到测试,但单剂量维生素C可以在术后第一天帮助控制手术后的疼痛。方法:100例在我院接受全髋关节置换术(THA)的患者被纳入这项前瞻性、双盲、安慰剂对照、随机试验。这些患者被随机分为对照组和维生素C组。对照组每天服用等量的安慰剂,而维生素C组在围手术期每天静脉注射3克维生素C。10毫升吗啡被皮下注射,作为手术后抱怨不适的病人的紧急镇痛药。用于抢救性镇痛的吗啡用量和炎症标志物水平是我们评估的主要结果。此外,我们使用视觉模拟评分(VAS)作为次要结果评估术后疼痛和髋关节恢复。结果:维生素C组皮下注射吗啡用量明显低于对照组(0 ~ 24h 6.1mg±2.7mg vs 4.0mg±2.9mg, p = 0.000;总用量8.3mg±3.1mg vs 6.6mg±3.9mg, p = 0.018)。在围手术期,维生素C组在休息和运动期间有更好的髋关节运动和更低的VAS疼痛水平。
期刊介绍:
Drug Design, Development and Therapy is an international, peer-reviewed, open access journal that spans the spectrum of drug design, discovery and development through to clinical applications.
The journal is characterized by the rapid reporting of high-quality original research, reviews, expert opinions, commentary and clinical studies in all therapeutic areas.
Specific topics covered by the journal include:
Drug target identification and validation
Phenotypic screening and target deconvolution
Biochemical analyses of drug targets and their pathways
New methods or relevant applications in molecular/drug design and computer-aided drug discovery*
Design, synthesis, and biological evaluation of novel biologically active compounds (including diagnostics or chemical probes)
Structural or molecular biological studies elucidating molecular recognition processes
Fragment-based drug discovery
Pharmaceutical/red biotechnology
Isolation, structural characterization, (bio)synthesis, bioengineering and pharmacological evaluation of natural products**
Distribution, pharmacokinetics and metabolic transformations of drugs or biologically active compounds in drug development
Drug delivery and formulation (design and characterization of dosage forms, release mechanisms and in vivo testing)
Preclinical development studies
Translational animal models
Mechanisms of action and signalling pathways
Toxicology
Gene therapy, cell therapy and immunotherapy
Personalized medicine and pharmacogenomics
Clinical drug evaluation
Patient safety and sustained use of medicines.